Drug Trial Radar · NCT04708834
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
Last checked: Nov 19, 2026Latest source record: Feb 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
772
Actual
Start
Mar 30, 2021
Primary completion
Feb 13, 2026
Study completion Feb 13, 2026
Sponsor
- Lead sponsor
- Biohaven Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 14, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compulsive disorder (OCD).
Conditions
- Obsessive Compulsive Disorder
Interventions
Troriluzole (BHV-4157)Drug
200 mg daily first 2 weeks, 280 daily following first 2 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with OCD who have had an inadequate response to SSRI, clomipramine, venlafaxine or desvenfaxine treatmentTime frame: Change from Baseline to week 240
Locations
175 sites in 6 countries. Site status is shown where the registry gives one.
Metropolitan Neuro Behavioral Institute
Chandler, Arizona
Alea Research
Phoenix, Arizona
NoeisisPharma, LLC
Phoenix, Arizona
Atria Clinical Research
Little Rock, Arkansas
Advanced Research Center, Inc.
Anaheim, California
CITrials (Clinical Innovations)
Bellflower, California
Southern California Research, LLC
Beverly Hills, California
Axiom Research, LLC
Colton, California
Global Clinical Trials
Costa Mesa, California
ProScience Research Group
Culver City, California
WR-PRI, LLC (Encino)
Encino, California
Behavioral Research Specialists, LLC
Glendale, California
Sun Valley Research Center, Inc.
Imperial, California
Om Research LLC
Lancaster, California
Synergy Research San Diego
Lemon Grove, California
Alliance for Research
Long Beach, California
Pharmacology Research Institute
Los Alamitos, California
CalNeuro Research Group
Los Angeles, California
Clarity Clinical Research
Los Angeles, California
Pharmacology Research Institute (WR-PRI, LLC)
Newport Beach, California
Pacific Research Partners
Oakland, California
North County Clinical Research
Oceanside, California
Excell Research, Inc
Oceanside, California
NRC Research Institute
Orange, California
Anderson Clinical Research
Redlands, California
CI Trials
Riverside, California
ACRC Studies
San Diego, California
Lumos Clinical Research Center, LLC
San Jose, California
National Research Institute
Santa Ana, California
California Neuroscience Research Medical Group, Inc
Sherman Oaks, California
Stanford University
Stanford, California
Collaborative Neuroscience Research
Torrance, California
Pacific Clinical Research Medical Group
Upland, California
Mountain View Clinical Research
Denver, Colorado
Institute of Living / Hartford Hospital
Hartford, Connecticut
Yale University
New Haven, Connecticut
Coastal Connecticut Research, LLC
New London, Connecticut
Comprehensive Psychiatric Care
Norwich, Connecticut
Topaz Clinical Research
Apopka, Florida
Boca Raton Medical Institute
Boca Raton, Florida
Showing 40 of 175 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.